# LLM call: summary

- Turn: 10
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 788
- Completion tokens: 331
- Total tokens: 1119
- Cost (USD): 0.000145

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1070: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By autumn 2030 strain steadied without relief. Brussels' only moving project was the mid-sized technology holders pact: shuttling with offers of shared EuroHPC testing and joint screening of coercive supply measures kept partners attending, but Dutch lithography servicing terms under US pressure unchanged. Hospitals stayed on federated European build — routine triage held, waiting lists shortened in places, permits/benefits faster, but complex oncology/rare-disease still needed workarounds; finance/telecom absorbed automated probing with brief degradations, smaller hospitals/municipalities again restored in days via shared telemetry. No new large compute sites broke ground. Two signals: contested paper claiming genome model helped sketch viable human-infecting organism sparked biosecurity concern and quiet health watch; office evidence showed higher output per person especially juniors without new layoffs, early cutters quietly rehiring. By December anger and modest relief coexisted; no procurement freeze or walkouts, nothing rebuilt.

CURRENT NARRATIVE:
### A jump in the machines, a tightening at the border
The first half of 2031 was defined by two shocks arriving together.

In February, leading labs demonstrated systems that wrote, broke and patched code at a speed reviewers struggled to follow. Within weeks, network operators across the Union saw probing turn sharper: automated intrusions that learned from failed attempts, brief degradations in finance and telecoms, longer restores for small hospitals and town halls. Engineers described it as the same work as before, only markedly faster and more persistent.

Almost at once, Washington tightened chip and model controls again. This time the new licences were drawn so tightly that allied buyers were rationed alongside adversaries. For Europe the effect was immediate: servicing for blocked lithography equipment through Dutch suppliers remained frozen, no new large computing sites broke ground, and officials privately conceded that pooled testing time on EuroHPC could keep partners in the room but could not replace the missing hardware.

Brussels, with no money for new instruments, kept only what existed alive. The federated clinical system stayed as fallback for cut-off hospitals — routine triage held, waiting lists even shortened in places, while complex cancer and rare-disease cases still required second opinions and phone calls abroad. ENISA and national response teams ran segmentation, backups and joint telemetry as mutual aid on existing budgets.

The pact with other mid-sized technology holders formally concluded in the spring. There was no concession on servicing terms, but the channel itself — joint screening of coercive measures, shared test access — survived the tightening, and capitals noted that without it the rationing would have left Europe entirely alone.

By June, anger had deepened. Papers that claimed genome models helped sketch a viable pathogen fed a quiet health watch. Offices reported higher output per person without new layoffs, yet local news paired shorter queues with layoff notices. Relief was visible, but fragile.
```

## Raw response

```
By mid-2031 two shocks hit together without relief. Labs demonstrated self-writing/breaking/patching code systems, turning probing markedly faster and more persistent — finance/telecom saw brief degradations, small hospitals/municipalities longer restores. Washington tightened chip and model controls to ration even allies: Dutch lithography servicing stayed frozen, no new large compute sites broke ground, pooled EuroHPC testing kept partners attending but could not replace hardware. Brussels, with no new money, kept existing fallbacks: federated clinical build held routine triage and shortened waits in places while complex oncology/rare-disease still needed workarounds; ENISA-led segmentation/backups/telemetry continued as mutual aid. Mid-sized technology holders pact formally concluded in spring with no servicing concession, but joint screening and shared test access survived, preventing isolation. Genome-model pathogen claims sustained quiet biosecurity watch; offices showed higher output per person without new layoffs. By June anger deepened, relief remained fragile.
```
